Eculizumab in Shiga-toxin Related Hemolytic and Uremic Syndrome Pediatric Patients - ECULISHU

Clinical trial NCT02205541 · COMPLETED

Trial details

NCT number: NCT02205541
Sponsor: University Hospital, Toulouse
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hemolytic Uremic Syndrome of Childhood

Start date: 2015-06-01
Primary completion: 2018-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.